Peculiarities of blood formation from bone marrow in secondary chronic inflammation on the background of mesenchymal stem cells
Keywordssecondary chronic inflammation, bone marrow, hematopoiesis, mesenchymal stem cells
The use of MSCs reduces the chronicity of inflammation due to greater activation of hematopoiesis, and, consequently, the entry of leukocytes into the blood and the focus in the initial stages of inflammation. The study of bone marrow hematopoiesis in the dynamics of secondary chronic inflammation shows that the use of MSCs reduces the chronicity of the process. This proves the possibility of using MSCs to prevent chronic inflammation.
Thus, inflammation on the background of the application of MSCs compared with the natural course of the process in the early stages of inflammation in the cell emigrates more leukocytes, compared with more distant terms, as they are less. In the early stages, there is more release of cells from the bone marrow into the blood, hematopoiesis is more significantly stimulated, and in the later stages, corresponding to the period of chronic inflammation - less activation of hematopoiesis.
This is probably because the increased migration of leukocytes into the site of inflammation in the early stages of the process provides a more effective fight against inflammation and, consequently, less likely to chronicle the process.
The use of MSCs leads to a decrease in the chronicity of inflammation due to greater activation of hematopoiesis, and, consequently, the entry of leukocytes into the blood and hearth in the initial stages of inflammation.
The results of our studies of bone marrow hematopoiesis in the dynamics of secondary chronic inflammation show that the use of MSCs reduces the chronicity of the process.
The prospect of further research is related to the improvement of pathogenetic therapy and the prevention of chronic inflammation. Further additional research should be conducted to study not only the local effect of MSCs on the course of inflammation but also the systemic administration of MSCs.
Chronic inflammation: molecular pathophysiology, nutritional and therapeutic Interventions / eds. : S. Roy, D. Bagchi, S. P. Raychaudhuri. – Boca Raton : CRC Press, 2012. – 472 p.
Don't sit on chronic inflammation / T. J. White, A. Cronin, M. F. Lo [et al.] // ANZ J. Surg. – 2012. – Vol. 82, N 3. – P. 181–182.
Klymenko N. Hematological mechanisms of chronic inflammation/ Klymenko N., Shevchenko O. – Kharkiv: HNMU, 2010. – 88 p.
Dranik G. Clinical immunology and allergology/Poligraphia Plus, Dranik G. 2010. – 604 p.
Gusev E. Systemic inflammation: Theoretical and metrological aspects of the pathological process model. Issue 2. Evolutional aspects Gusev E. Chereshkov V.// Patologicheskaya Phisiologia I Eksperimentalnaya terapia. – 2013. – № 1. – P. 3–14.
Gusev E. Systemic inflammation: Theoretical and metrological aspects of the pathological process model. Issue 1. General characteristics of the process / Gusev E., Chereshkov V.// Patologicheskaya Phisiologia I Eksperimentalnaya terapia. – 2012. – № 4. – P. 3–14.
Klymenko N. The Role of Inflammation in Pathology/ Klymenko N. // Zagalna Patologia ta Patologichna Phisiologia. – 2010. – № 2. – P. 20–21.
Odynets U. G-KSF in Complex treatment inflammation diseases of infection genesis, which do not accompanied by neutropenia / Odynets U. Klymenko N., Shevchenko O. // Vrachebnaya Practica. – 2004. – № 5. – P. 32–42.
Shevchenko O. Bone Marrow Hematopoiesis in Secondary Chronic Inflammation on the Background of Natrii Nucleinat / Shevchenko O. Kovalenko L.// Еksperymentalna I Clinichna Medicyna.– 2013. – №2 (59). – P. 67-73.
Chumakova M. Likopid – effective and safe immunotropic tool / Chumakova M. // Farmacia. – 2002. – № 3. – P. 34-35.
Nikitin O. A Search of Effective Modulators Cytokine Productiveness Function of macrophages/ Nikitin O., Abidov M, Kovalevskaya E. And others // Bulleten Eksperimentalnoy Biologii I Mediciny. – 2004. – № 9. – P. 293-295.
Klymenko N. Justification for the Model of Chronic (secondary chronic) inflammation / Klymenko N., Shevchenko O., Tatarko O., Gubina-Vakulik G.// Еksperymentalna I Clinichna Medicyna.– 2007. – № 2. – P. 24–28.
Klymenko N. The role of Leukocytes in the reaction of mast cells in the focus of inflammation / Klymenko N // Bulleten Eksperimentalnoy Biologii I Mediciny. – 1993. – № 9. – P. 249–253.
Mashkovskiy M. Medicines: Follow up for Doctors / М Mashkovskiy M – 16-е Issue. – М. : Novaya Volna, 2010. – 1216 p.
Fougère B, Boulanger E, Nourhashémi F, Guyonnet S, Cesari M. Chronic Inflammation: Accelerator of Biological Aging. J Gerontol A BiolSci Med Sci. 2017 Sep 1;72(9):1218-1225. doi: 10.1093/gerona/glw240. Retraction in: J Gerontol A BiolSci Med Sci. 2019 Feb 15;74(3):431. PMID: 2800-3373.
Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. TrendsMolMed. 2001 Jun;7(6):259-64. doi: 10.1016/s1471-4914(01)02016-0. PMID: 11378515.
Wang LT, Ting CH, Yen ML, Liu KJ, Sytwu HK, Wu KK, Yen BL. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J BiomedSci. 2016 Nov 4;23(1):76. doi: 10.1186/s12929-016-0289-5. PMID: 27809910; PMCID: PMC5095977.
Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? StemCells. 2013 Oct;31(10):2033-41. doi: 10.1002/stem.1452. PMID: 23766124.
Hoeck JD, Biehs B, Kurtova AV, Kljavin NM, de Sousa E Melo F, Alicke B, Koeppen H, Modrusan Z, Piskol R, deSauvage FJ. Stem cell plasticity enables hair regeneration following Lgr5+ cell loss. NatCellBiol. 2017 Jun;19(6):666-676. doi: 10.1038/ncb3535. Epub 2017 May 29. PMID: 28553937.
Laboratory Methods of Investigations in the Clinic/ Menshikov V – М. : Medicina, 1987. – 364 p.
Kolobovnikova U. The Fiches of Functional Activity Eosinophilic Granulocytes in Blood with Lung Tuberculosis. / Kolobovnikova U, Ukazova O. Ukazova V, Novitskiy V. // Bulleten Sibirskoy Mediciny. – 2014. – I. 13. – № 5. – P. 42-48.
Dygay O. Inflammation and Hematopoiesis./ Dygay O., N. Klymenko. – Tomsk: Izdatelstvo Tomskogo Universiteta, 1992. – 275 p.
Dygay O. The Theory of Hematopoiesis Regulation / Dygay O. // Bulleten Sibirskoy Mediciny. – 2004. – № 4. – P. 5–17.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 280
Number of citations: 0